Skip to main content

QED finalist

Our project “GRAPLON Aerosolized Nanomedicines for Treating Cystic Fibrosis Lung Infections” has been selected as a finalist for a QED Proof-of-Concept award from the Science Center in Philadelphia. This program provides funding and business advice to help academic researchers commercialize promising technologies. News release at